David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$667M |
| 2 |
NVIDIA
NVDA
|
+$584M |
| 3 |
ConocoPhillips
COP
|
+$432M |
| 4 |
Amazon
AMZN
|
+$418M |
| 5 |
Johnson & Johnson
JNJ
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$836M |
| 2 |
Meta Platforms (Facebook)
META
|
+$525M |
| 3 |
Apple
AAPL
|
+$453M |
| 4 |
CELG
Celgene Corp
CELG
|
+$349M |
| 5 |
Pfizer
PFE
|
+$306M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.27% |
| 2 | Consumer Discretionary | 13.7% |
| 3 | Healthcare | 13.3% |
| 4 | Industrials | 7.34% |
| 5 | Financials | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Agilysys
AGYS
$3.23B
| $921K | ﹤0.01% |
42,912
-37,137
| -46% | -$770K |
|
2677
CALL
Warner Bros
WBD
$72.5B
| $921K | ﹤0.01% |
30,000
| – | – |
|
2678
Ingles Markets
IMKTA
$1.61B
| $920K | ﹤0.01% |
29,566
-3,498
| -11% | -$103K |
|
2679
PUT
Invesco
IVZ
$14.4B
| $917K | ﹤0.01% |
44,800
-20,000
| -31% | -$415K |
|
2680
CALL
Ameriprise Financial
AMP
$49.5B
| $915K | ﹤0.01% |
6,300
-6,800
| -52% | -$983K |
|
2681
PUT
Kinsale Capital Group
KNSL
$8.84B
| $915K | ﹤0.01% |
+10,000
| New | +$799K |
|
2682
PUT
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$284M
| $913K | ﹤0.01% |
12
| – | – |
|
2683
BGC Group
BGC
$5.61B
| $911K | ﹤0.01% |
174,037
-388,260
| -69% | -$2.01M |
|
2684
Mammoth Energy Services
TUSK
$153M
| $911K | ﹤0.01% |
132,384
+38,439
| +41% | +$488K |
|
2685
CALL
Vornado Realty Trust
VNO
$7.46B
| $910K | ﹤0.01% |
14,200
| – | – |
|
|
IOTS
2686
DELISTED
Adesto Technologies Corp
IOTS
| $905K | ﹤0.01% |
111,075
+84,127
| +312% | +$603K |
|
|
MDSO
2687
CALL
DELISTED
Medidata Solutions, Inc.
MDSO
| $905K | ﹤0.01% |
+10,000
| New | +$878K |
|
2688
Madrigal Pharmaceuticals
MDGL
$11.8B
| $904K | ﹤0.01% |
8,627
+5,747
| +200% | +$616K |
|
2689
New Mountain Finance
NMFC
$719M
| $902K | ﹤0.01% |
64,543
-24,556
| -28% | -$343K |
|
|
HAPN
2690
Happen Inc
HAPN
$2.11B
| $901K | ﹤0.01% |
54,985
+17,766
| +48% | +$280K |
|
2691
PUT
Edgewell Personal Care
EPC
$1.33B
| $900K | ﹤0.01% |
+33,400
| New | +$1.19M |
|
2692
Expro Ltd
XPRO
$1.98B
| $900K | ﹤0.01% |
27,469
-23,429
| -46% | -$847K |
|
|
ESV
2693
PUT
DELISTED
Ensco Rowan plc
ESV
| $899K | ﹤0.01% |
+105,400
| New | +$1.22M |
|
2694
Duluth Holdings
DLTH
$144M
| $898K | ﹤0.01% |
66,106
-6,398
| -9% | -$104K |
|
2695
PUT
Bunge Global
BG
$21.5B
| $897K | ﹤0.01% |
16,100
-30,000
| -65% | -$1.6M |
|
|
CZZ
2696
DELISTED
Cosan Limited
CZZ
| $896K | ﹤0.01% |
67,056
-1,419
| -2% | -$17.5K |
|
2697
Axsome Therapeutics
AXSM
$10.8B
| $895K | ﹤0.01% |
+34,756
| New | +$697K |
|
2698
PUT
BlackBerry
BB
$4.57B
| $895K | ﹤0.01% |
120,000
| – | – |
|
2699
Natera
NTRA
$48.5B
| $891K | ﹤0.01% |
32,309
-137,729
| -81% | -$3.04M |
|
2700
CALL
Everest Group
EG
$14.4B
| $890K | ﹤0.01% |
3,600
-9,900
| -73% | -$2.38M |
|
Similar funds
David Shaw's Q2 2019 Portfolio in Review
As of Q2 2019, David Shaw held 4,048 positions worth $80.2B, up 3.6% from $77.4B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
David Shaw's Q2 2019 filing shows 499 new, 1,419 increased, 1,452 reduced and 416 closed positions. Its largest new stake was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M. The largest sale was Qualcomm, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q2 2019 buy was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M.
- David Shaw added most to Alibaba in Q2 2019, an estimated $667M increase.
- David Shaw's biggest Q2 2019 reduction was Qualcomm, cutting an estimated $836M.
- David Shaw fully exited iShares Core S&P 500 ETF in Q2 2019, selling an estimated $42.7M.
- David Shaw's ten largest holdings make up 9.8% of its $80.2B portfolio in Q2 2019.
- David Shaw opened 499 new positions and closed 416 in Q2 2019.
- David Shaw's portfolio value rose 3.6% quarter-over-quarter to $80.2B.
Based on D.E. Shaw & Co's 13F filing for Q2 2019, filed 14 Aug 2019.